Global Antiviral Drugs Market Worth $63.11 Billion by 2022

0

No comments posted yet

Comments

Slide 1

Global Antiviral Drugs Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

Slide 2

Global Antiviral Drugs Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022 Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Browse the report: http://www.orbisresearch.com/reports/index/antiviral-drugs-global-market-outlook-2016-2022 Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market. HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

Slide 3

Global Antiviral Drugs Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022 Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/249840 Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

Slide 4

About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Global Antiviral Drugs Market Primary Research, Risk Analysis, Product Research, Trends and Forecast by 2022

Summary: Market research report with industry analysis on "Global Antiviral Drugs Market Outlook and Forecast 2022" is made available by Orbis Research.

Tags: global antiviral drugs market size forecast

URL: